| SRZN |
Surrozen, Inc. |
Common Stock, par value $0.0001 per share |
8.5% |
$15,649,459 |
+$3,477,006 |
726,193 |
+29% |
Millennium Management LLC |
31 Dec 2025 |
| BTAI |
BioXcel Therapeutics, Inc. |
Common Stock, par value $0.001 per share |
8.4% |
$3,762,144 |
+$1,654,635 |
1,835,192 |
+79% |
Millennium Management LLC |
31 Dec 2025 |
| RVPH |
Reviva Pharmaceuticals Holdings, Inc. |
Common Stock, par value $0.0001 per share |
8.2% |
$579,253 |
|
1,072,690 |
|
Integrated Core Strategies (US) LLC |
30 Jun 2026 |
|
Churchill Capital Corp XIII |
Class A Ordinary Shares, par value $0.0001 per share |
8.1% |
|
|
3,368,778 |
|
Millennium Management LLC |
31 Jul 2026 |
| ARDX |
Ardelyx, Inc. |
Common Stock, par value $0.0001 per share |
7.4% |
$108,083,380 |
+$29,483,912 |
18,043,970 |
+38% |
Millennium Management LLC |
31 Mar 2026 |
| VYGR |
Voyager Therapeutics, Inc. |
Common Stock, par value $0.001 per share |
7.4% |
$16,794,355 |
+$3,912,232 |
4,442,951 |
+30% |
Millennium Management LLC |
30 Jun 2026 |
| MYGN |
Myriad Genetics, Inc. |
Common Stock, par value $0.01 per share |
7.2% |
$41,205,972 |
+$12,003,761 |
6,700,158 |
+41% |
Millennium Management LLC |
31 Dec 2025 |
| QNCX |
Quince Therapeutics, Inc. |
Common Stock, par value $0.001 per share |
7.2% |
$1,740,584 |
|
1,403,697 |
|
Millennium Management LLC |
04 Jun 2026 |
| IMUX |
Immunic, Inc. |
Common Stock, par value $0.0001 per share |
7% |
$14,194,168 |
|
969,547 |
|
Millennium Management LLC |
30 Jun 2026 |
| IEAGU |
Infinite Eagle Acquisition Corp. |
Class A Ordinary Shares, par value $0.0001 per share |
6.8% |
$24,055,500 |
-$6,090,000 |
2,370,000 |
-20% |
Millennium Management LLC |
31 Mar 2026 |
|
Harvard Ave Acquisition Corporation |
Class A Ordinary Shares, par value $0.0001 per share |
6.4% |
|
|
950,000 |
|
Millennium Management LLC |
23 Oct 2025 |
| ANTX |
AN2 Therapeutics, Inc. |
Common Stock, par value $0.00001 per share |
6.3% |
$2,952,975 |
|
2,237,102 |
|
Millennium Management LLC |
06 Mar 2026 |
| RVPH |
Reviva Pharmaceuticals Holdings, Inc. |
Common Stock, par value $0.0001 per share |
6.2% |
$174,669 |
-$542,018 |
793,952 |
-76% |
Integrated Core Strategies (US) LLC |
23 Mar 2026 |
| LYFT |
Lyft, Inc. |
Class A Common Stock, par value $0.00001 per share |
6.1% |
$441,831,536 |
|
24,276,458 |
|
Millennium Management LLC |
11 Feb 2026 |
| BEBE |
TGE Value Creative Solutions Corp |
Class A Ordinary Shares, par value $0.0001 per share |
6% |
|
|
900,000 |
|
Millennium Management LLC |
19 Dec 2025 |
| ZEPP |
Zepp Health Corporation |
Class A Ordinary Shares, par value $0.0001 per share |
5.8% |
$303,726,978 |
|
6,634,592 |
|
Millennium Management LLC |
05 Nov 2025 |
| SPRB |
Spruce Biosciences, Inc. |
Common Stock, par value $0.0001 per share |
5.8% |
$7,788,261 |
+$2,803,863 |
160,981 |
+56% |
Integrated Core Strategies (US) LLC |
30 Jun 2026 |
| IMUX |
Immunic, Inc. |
Common Stock, par value $0.0001 per share |
5.7% |
$920,600 |
|
793,621 |
|
Millennium Management LLC |
29 Apr 2026 |
| BBT |
Beacon Financial Corporation |
Common Stock, par value $0.01 per share |
5.6% |
$145,975,023 |
|
4,701,289 |
|
Millennium Management LLC |
20 Mar 2026 |
| QNRX |
Quoin Pharmaceuticals Ltd. |
Ordinary Shares, no par value per share |
5.5% |
$22,755,775 |
+$7,279,879 |
3,850,385 |
+47% |
Integrated Core Strategies (US) LLC |
26 May 2026 |
| KPTI |
Karyopharm Therapeutics Inc. |
Common Stock, par value $0.0001 per share |
5.5% |
$7,252,280 |
|
1,008,662 |
|
Millennium Management LLC |
04 Feb 2026 |
| SLVM |
Sylvamo Corporation |
Common Stock, par value $1.00 per share |
5.4% |
$88,221,844 |
|
2,148,608 |
|
Millennium Management LLC |
18 Nov 2025 |
| OFRM |
Once Upon a Farm, PBC |
Common Stock, par value $0.0001 per share |
5.4% |
$36,941,906 |
|
2,262,211 |
|
Millennium Management LLC |
04 Jun 2026 |
| EDSA |
Edesa Biotech, Inc. |
Common Shares, without par value |
5.4% |
$4,092,584 |
|
520,685 |
|
Integrated Core Strategies (US) LLC |
11 Jun 2026 |
| TPG |
TPG Inc. |
Class A Common Stock, par value $0.001 per share |
5.2% |
$336,104,949 |
+$57,825,613 |
8,029,263 |
+21% |
Millennium Management LLC |
11 Jun 2026 |
| AMN |
AMN Healthcare Services, Inc. |
Common Stock, par value $0.01 per share |
5.2% |
$31,614,024 |
-$6,935,314 |
2,005,966 |
-18% |
Millennium Management LLC |
31 Dec 2025 |
| CDXS |
Codexis, Inc. |
Common Stock, par value $0.0001 per share |
5.2% |
$7,812,135 |
|
4,734,627 |
|
Integrated Core Strategies (US) LLC |
09 Apr 2026 |
| IBIO |
iBio, Inc. |
Common Stock, par value $0.001 per share |
5.2% |
$2,381,068 |
|
1,235,827 |
|
Millennium Management LLC |
15 Jan 2026 |
| HLXC |
Helix Acquisition Corp. III |
Class A Ordinary Shares, par value $0.0001 per share |
4.8% |
$8,694,125 |
-$2,466,990 |
855,721 |
-22% |
Millennium Management LLC |
31 Mar 2026 |
| COLL |
Collegium Pharmaceutical, Inc. |
Common Stock, par value $0.001 per share |
4.7% |
$50,249,865 |
|
1,519,500 |
|
Millennium Management LLC |
07 May 2026 |
| SLRN |
ACELYRIN, INC. |
Common Stock, par value $0.00001 per share |
4.7% |
$11,550,285 |
|
4,714,402 |
|
Integrated Core Strategies (US) LLC |
31 Dec 2024 |
| HLXB |
Helix Acquisition Corp. II |
Class A Ordinary Shares, par value $0.0001 per share |
4.7% |
$9,555,723 |
|
897,251 |
|
Millennium Management LLC |
30 Jun 2025 |
| LIVN |
LivaNova PLC |
Ordinary Shares, par value GBP 1.00 per share |
4.4% |
$155,001,929 |
-$66,446,323 |
2,438,671 |
-30% |
Millennium Management LLC |
31 Mar 2026 |
| TE |
T1 Energy Inc. |
Common Stock, par value $0.01 per share |
4.4% |
$90,748,054 |
|
12,346,674 |
|
Millennium Management LLC |
29 Jul 2026 |
| ADPT |
Adaptive Biotechnologies Corporation |
Common Stock, par value $0.0001 per share |
4.3% |
$49,711,809 |
|
6,292,634 |
|
Millennium Management LLC |
31 Dec 2024 |
| PYXS |
Pyxis Oncology, Inc. |
Common Stock, par value $0.001 per share |
4% |
$2,587,602 |
-$698,942 |
2,488,079 |
-21% |
Millennium Management LLC |
31 Mar 2025 |
| CPIX |
Cumberland Pharmaceuticals Inc. |
Common Stock, no par value |
4% |
$1,618,467 |
-$571,171 |
598,634 |
-26% |
Integrated Core Strategies (US) LLC |
30 Sep 2025 |
| BRZE |
Braze, Inc. |
Class A Common Stock, par value $0.0001 per share |
3.9% |
$103,515,424 |
-$45,149,309 |
4,384,389 |
-30% |
Millennium Management LLC |
31 Mar 2026 |
| FHN |
First Horizon Corporation |
Common Stock, par value $0.625 per share |
3.8% |
$449,728,427 |
-$157,467,779 |
18,817,089 |
-26% |
Millennium Management LLC |
31 Dec 2025 |
| ACCD |
Accolade, Inc. |
Common Stock, par value $0.0001 per share |
3.8% |
$21,697,844 |
|
3,090,861 |
|
Millennium Management LLC |
31 Dec 2024 |
| SEE |
Sealed Air Corporation |
Common Stock, par value $0.10 per share |
3.7% |
$181,370,784 |
-$72,119,443 |
5,397,940 |
-28% |
Millennium Management LLC |
11 Nov 2025 |
| CMA |
Comerica Incorporated |
Common Stock, par value $5 per share |
3.6% |
$315,762,635 |
-$279,206,324 |
4,608,328 |
-47% |
Millennium Management LLC |
07 Oct 2025 |
| AMG |
Affiliated Managers Group, Inc. |
Common Stock, par value $0.01 per share |
3.6% |
$242,510,253 |
-$116,590,124 |
1,017,113 |
-32% |
Millennium Management LLC |
30 Sep 2025 |
| FWRG |
First Watch Restaurant Group, Inc. |
Common Stock, par value $0.01 per share |
3.6% |
$28,265,334 |
-$11,306,064 |
2,192,811 |
-29% |
Millennium Management LLC |
30 Jun 2026 |
| AMAN |
Amanat Acquisition Corp |
Class A Ordinary Shares, par value $0.0001 per share |
3.5% |
$2,797,501 |
-$4,266,898 |
276,160 |
-60% |
Millennium Management LLC |
30 Jun 2026 |
| CYRX |
Cryoport, Inc. |
Common Stock, par value $0.001 per share |
3.4% |
$27,078,198 |
-$23,865,193 |
1,724,726 |
-47% |
Millennium Management LLC |
30 Jun 2026 |
| KIDS |
OrthoPediatrics Corp. |
Common Stock, par value $0.00025 per share |
3.2% |
$15,626,040 |
-$10,977,349 |
816,830 |
-41% |
Millennium Management LLC |
30 Jun 2026 |
| LXEO |
Lexeo Therapeutics, Inc. |
Common Stock, par value $0.0001 per share |
3.2% |
$15,362,583 |
-$3,470,396 |
2,313,642 |
-18% |
Millennium Management LLC |
30 Sep 2025 |
| GVA |
Granite Construction Incorporated |
Common Stock, par value $0.01 per share |
3% |
$102,538,079 |
|
1,283,009 |
|
Millennium Management LLC |
31 Mar 2025 |
| NKTR |
Nektar Therapeutics |
Common Stock, par value $0.0001 per share |
3% |
$32,489,559 |
-$20,590,346 |
570,994 |
-39% |
Millennium Management LLC |
30 Sep 2025 |
| CMPS |
COMPASS Pathways plc |
American Depositary Shares, each representing one ordinary share, par value of GBP 0.008 per share |
3% |
$10,456,174 |
-$2,412,525 |
2,773,521 |
-19% |
Millennium Management LLC |
31 Mar 2025 |
| UTZ |
Utz Brands, Inc. |
Class A Common Stock, par value $0.0001 per share |
2.9% |
$26,388,721 |
-$20,572,134 |
2,542,217 |
-44% |
Millennium Management LLC |
31 Dec 2025 |
| NEO |
NeoGenomics, Inc. |
Common Stock, par value $0.001 per share |
2.8% |
$26,073,366 |
-$24,761,251 |
3,566,808 |
-49% |
Millennium Management LLC |
30 Jun 2025 |
| UWMC |
UWM Holdings Corporation |
Class A Common Stock, par value $0.0001 per share |
2.5% |
$21,192,426 |
-$32,680,198 |
4,974,748 |
-61% |
Millennium Management LLC |
30 Jun 2025 |
| ENTA |
Enanta Pharmaceuticals, Inc. |
Common Stock, par value $0.01 per share |
2.3% |
$10,572,650 |
-$7,381,243 |
670,428 |
-41% |
Millennium Management LLC |
31 Dec 2025 |
| KPTI |
Karyopharm Therapeutics Inc. |
Common Stock, par value $0.0001 per share |
2.3% |
$306,943 |
|
511,571 |
|
Millennium Management LLC |
31 Mar 2026 |
| KRUS |
Kura Sushi USA, Inc. |
Class A Common Stock, par value $0.001 per share |
2.1% |
$16,446,851 |
-$27,082,428 |
235,662 |
-62% |
Integrated Core Strategies (US) LLC |
31 Mar 2026 |
| TENX |
Tenax Therapeutics, Inc. |
Common Stock, par value $0.0001 per share |
2.1% |
$7,986,979 |
+$3,293,848 |
533,889 |
+70% |
Millennium Management LLC |
31 Mar 2026 |
| OPRT |
Oportun Financial Corporation |
Common Stock, par value $0.0001 per share |
2.1% |
$5,399,221 |
-$7,422,883 |
945,987 |
-58% |
Millennium Management LLC |
30 Jun 2026 |
| ANGO |
AngioDynamics, Inc. |
Common Stock, par value $0.01 per share |
2% |
$10,818,316 |
-$16,734,886 |
842,548 |
-61% |
Millennium Management LLC |
31 Dec 2025 |
| ABEO |
Abeona Therapeutics Inc. |
Common Stock, par value $0.01 per share |
1.7% |
$4,292,820 |
|
809,966 |
|
Millennium Management LLC |
31 Mar 2025 |
| JSPR |
Jasper Therapeutics, Inc. |
Voting Common Stock, par value $0.0001 per share |
1.7% |
$228,859 |
-$536,778 |
486,933 |
-70% |
Millennium Management LLC |
30 Jun 2026 |
| BKU |
BankUnited, Inc. |
Common Stock, par value $0.01 per share |
1.3% |
$46,696,388 |
|
963,758 |
|
Millennium Management LLC |
30 Jun 2026 |
| UNCY |
Unicycive Therapeutics, Inc. |
Common Stock, par value $0.001 per share |
1% |
$2,087,497 |
-$6,930,313 |
271,456 |
-77% |
Millennium Management LLC |
30 Jun 2026 |
| MIST |
Milestone Pharmaceuticals Inc. |
Common Shares, no par value |
0.6% |
$396,161 |
|
322,082 |
|
Integrated Core Strategies (US) LLC |
31 Mar 2025 |
| ATXS |
Astria Therapeutics, Inc. |
Common Stock, par value $0.001 per share |
0.4% |
$1,616,895 |
-$19,770,311 |
222,101 |
-92% |
Millennium Management LLC |
14 Oct 2025 |
| ANIP |
ANI Pharmaceuticals, Inc. |
Common Stock, par value $0.0001 per share |
0.3% |
$5,976,442 |
-$96,309,614 |
65,245 |
-94% |
Millennium Management LLC |
30 Sep 2025 |
| PHIN |
PHINIA Inc. |
Common Stock, par value $0.01 per share |
0% |
$0 |
|
0 |
|
Integrated Core Strategies (US) LLC |
31 Mar 2025 |
| GLNG |
Golar LNG Limited |
Common Shares, par value $1.00 per share |
0% |
$0 |
-$220,684,058 |
0 |
-100% |
Integrated Core Strategies (US) LLC |
31 Mar 2025 |
| CBRL |
Cracker Barrel Old Country Store, Inc. |
Common Stock, par value $0.01 per share |
0% |
$0 |
-$36,275,016 |
0 |
-100% |
Integrated Core Strategies (US) LLC |
31 Mar 2026 |